A Tripartite Collaborative Model for Identifying High-Risk in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Semaglutide Treatment Algorithm Starting With the Fibrosis-4 Index
Kanzo · 01.11.2026 · 67 (6) · 561-574
DOI: 10.2957/kanzo.67.561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kanzo, erschienen am 01.11.2026. Verfasst von Yoshihiro Kamada und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kamada, Y., Sumida, Y., Takahashi, H., Fujii, H., Kawanaka, M., Seko, Y., Ishiba, H., Imajo, K., Yoneda, M., Kawaguchi, T., & Nakajima, A. (2026). A Tripartite Collaborative Model for Identifying High-Risk in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Semaglutide Treatment Algorithm Starting With the Fibrosis-4 Index. Kanzo, 67(6), 561-574. https://doi.org/10.2957/kanzo.67.561
Vancouver
Kamada Y, Sumida Y, Takahashi H, Fujii H, Kawanaka M, Seko Y, et al. A Tripartite Collaborative Model for Identifying High-Risk in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Semaglutide Treatment Algorithm Starting With the Fibrosis-4 Index. Kanzo. 2026;67(6):561-574. doi:10.2957/kanzo.67.561
BibTeX
@article{Kamada2026,
author = {Kamada, Yoshihiro and Sumida, Yoshio and Takahashi, Hirokazu and Fujii, Hideki and Kawanaka, Miwa and Seko, Yuya and Ishiba, Hiroshi and Imajo, Kento and Yoneda, Masato and Kawaguchi, Takumi and Nakajima, Atsushi},
title = {A Tripartite Collaborative Model for Identifying High-Risk in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Semaglutide Treatment Algorithm Starting With the Fibrosis-4 Index},
journal = {Kanzo},
year = {2026},
volume = {67},
number = {6},
pages = {561--574},
doi = {10.2957/kanzo.67.561}
}
EUVIMED